HONORHEALTH SCOTTSDALE THOMPSON PEAK — History
CCN 030123 | 3-year financial timeline | COVID resilience: 56/100
🛡️ Public data only — no PHI permitted on this instance.
$188M
Latest Revenue (FY2022)
+7.7%
Revenue CAGR (3yr)
-1.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $162M | $183M | $188M | +2.9% | +7.7% |
| Operating Expenses | $161M | $179M | $191M | +6.5% | +9.0% |
| Operating Margin | 0.8% | 1.8% | -1.6% | -192.5% | +0.0% |
| Net Income | $1M | $3M | $-3M | -195.2% | +0.0% |
| Licensed Beds | 120 | 120 | 120 | +0.0% | +0.0% |
| Total Patient Days | 24,243 | 27,247 | 26,523 | -2.7% | +4.6% |
| Medicare Day % | 47% | 47% | 47% | -0.3% | -0.6% |
| Medicaid Day % | 7% | 7% | 8% | +24.0% | +7.5% |
COVID Impact & Recovery
Resilience Score: 56/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +16.1% ($162M → $188M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.7%
This Hospital
+7.6%
State Avg
Latest Margin
-1.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $201M | -2.8% |
| FY2024 (proj) | $214M | -4.0% |
| FY2025 (proj) | $227M | -5.2% |